Daily Signals
2489 companies scored · 2026-10-14 run in progress: 1692 of ~5379 signals so far · Alpha · vs marketSwitch to Total · 30D 90D
Distribution of the day's forecasts
30D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
256 companies
Sorted by market cap ↓ · forecast rankings are part of the paid plans
| Ticker | Rating | 30D | Δ | |
|---|---|---|---|---|
| BTSGBrightSpring Health Services, Inc. | Unlock rating and forecasts | |||
| DVADAVITA INC. | Unlock rating and forecasts | |||
| ALBALBEMARLE CORP | Unlock rating and forecasts | |||
| NVMINOVA LTD. | -0.10% | · | ||
| AVTRAvantor, Inc. | -0.09% | · | ||
| COOCOOPER COMPANIES, INC. | +0.15% | · | ||
| GMEDGLOBUS MEDICAL INC | -0.11% | · | ||
| CLXCLOROX CO /DE/ | Unlock rating and forecasts | |||
| ALGNALIGN TECHNOLOGY INC | -0.10% | · | ||
| ENSGENSIGN GROUP, INC | +0.16% | · | ||
| CGNXCOGNEX CORP | -0.08% | · | ||
| GKOSGLAUKOS Corp | Unlock rating and forecasts | |||
| BIOBIO-RAD LABORATORIES, INC. | -0.07% | · | ||
| PODDINSULET CORP | -0.11% | ▲ 1 | ||
| WMSADVANCED DRAINAGE SYSTEMS, INC. | -0.11% | · | ||
| TXG10x Genomics, Inc. | Unlock rating and forecasts | |||
| ESIElement Solutions Inc | +0.18% | ▼ 1 | ||
| BRKRBRUKER CORP | Unlock rating and forecasts | |||
| CAICaris Life Sciences, Inc. | Unlock rating and forecasts | |||
| RALRalliant Corp | Unlock rating and forecasts | |||
| WLKWESTLAKE CORP | Unlock rating and forecasts | |||
| ATRAPTARGROUP, INC. | -0.11% | ▲ 1 | ||
| EMNEASTMAN CHEMICAL CO | Unlock rating and forecasts | |||
| AXTAAxalta Coating Systems Ltd. | Unlock rating and forecasts | |||
| MSAMSA Safety Inc | Unlock rating and forecasts | |||
| CHECHEMED CORP | +0.16% | · | ||
| CAMTCAMTEK LTD | +0.13% | · | ||
| HXLHEXCEL CORP /DE/ | -0.06% | · | ||
| ICLICL Group Ltd. | -0.11% | · | ||
| ELFe.l.f. Beauty, Inc. | -0.10% | · | ||
| STSensata Technologies Holding plc | -0.10% | · | ||
| MOSMOSAIC CO | Unlock rating and forecasts | |||
| FMSFresenius Medical Care AG | Unlock rating and forecasts | |||
| BLCOBausch & Lomb Corp | Unlock rating and forecasts | |||
| RDNTRadNet, Inc. | Unlock rating and forecasts | |||
| HAEHAEMONETICS CORP | -0.10% | · | ||
| SXTSENSIENT TECHNOLOGIES CORP | Unlock rating and forecasts | |||
| BCPCBALCHEM CORP | -0.10% | · | ||
| TFXTELEFLEX INC | -0.11% | · | ||
| SHCSotera Health Co | -0.07% | · | ||
| CECelanese Corp | Unlock rating and forecasts | |||
| OPCHOption Care Health, Inc. | -0.11% | · | ||
| LFSTLifeStance Health Group, Inc. | -0.11% | · | ||
| PRMPerimeter Solutions, Inc. | Unlock rating and forecasts | |||
| BLLNBillionToOne, Inc. | Unlock rating and forecasts | |||
| HTFLHeartflow, Inc. | Unlock rating and forecasts | |||
| VNTVontier Corp | -0.11% | ▲ 1 | ||
| ITGRInteger Holdings Corp | Unlock rating and forecasts | |||
| LIVNLivaNova PLC | Unlock rating and forecasts | |||
| CBTCABOT CORP | -0.10% | · | ||
By sector
Median 30D forecast per sector. Click to filter.
Rating changes
Unlock the full ranking
Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.
See plans Create a free accountRatings are relative: the forecasts of the latest complete daily run (2026-10-13) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.